Search by Drug Name or NDC
NDC 00990-9257-39 Potassium Chloride in Sodium Chloride 1.49; 4.5 g/1000mL; g/1000mL Details
Potassium Chloride in Sodium Chloride 1.49; 4.5 g/1000mL; g/1000mL
Potassium Chloride in Sodium Chloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ICU Medical Inc.. The primary component is POTASSIUM CHLORIDE; SODIUM CHLORIDE.
Product Information
NDC | 00990-9257 |
---|---|
Product ID | 0990-9257_c84983c7-f279-443c-949f-f09a5a262358 |
Associated GPIs | 79992002102015 |
GCN Sequence Number | 052266 |
GCN Sequence Number Description | potassium chloride-0.45% NaCl IV SOLN 20 MEQ/L INTRAVEN |
HIC3 | C1D |
HIC3 Description | POTASSIUM REPLACEMENT |
GCN | 19854 |
HICL Sequence Number | 025281 |
HICL Sequence Number Description | POTASSIUM CHLORIDE IN 0.45 % SODIUM CHLORIDE |
Brand/Generic | Generic |
Proprietary Name | Potassium Chloride in Sodium Chloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | SODIUM CHLORIDE and POTASSIUM CHLORIDE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 1.49; 4.5 |
Active Ingredient Units | g/1000mL; g/1000mL |
Substance Name | POTASSIUM CHLORIDE; SODIUM CHLORIDE |
Labeler Name | ICU Medical Inc. |
Pharmaceutical Class | Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA078446 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00990-9257-39 (00990925739)
NDC Package Code | 0990-9257-39 |
---|---|
Billing NDC | 00990925739 |
Package | 12 POUCH in 1 CASE (0990-9257-39) / 1 BAG in 1 POUCH / 1000 mL in 1 BAG |
Marketing Start Date | 2020-03-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |